Cargando…

925. Infectious Complications Following Chimeric Antigen Receptor (CAR) T-cell Therapy

BACKGROUND: Chimeric antigen receptor (CAR-T) T-cell therapy is a novel immunotherapy for cancer treatment in which patients are treated with targeted, genetically-modified T-cells. Common side effects include cytokine release syndrome, neurotoxicity, hypogammaglobulinemia, and increased susceptibil...

Descripción completa

Detalles Bibliográficos
Autores principales:	Trottier, Caitlin, Larsen, Christian, Bindal, Poorva, Dodge, Laura E, Elavalakanar, Pavania, Knudsen, Elisabeth, Kim, Sirwoo, Logan, Emma, Urman, Arielle R, Frigault, Matthew, Fishman, Jay A, Arnason, Jon, Alonso, Carolyn D
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Oxford University Press 2021
Materias:	Poster Abstracts
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8644649/ http://dx.doi.org/10.1093/ofid/ofab466.1120

Ejemplares similares

2694. Infectious Complications in CAR-T Cell Therapy Recipients: A Systematic Review and Meta-Analysis
por: Banegas, Marcela, et al.
Publicado: (2023)

Complete responses to odronextamab in two patients with diffuse large B‐cell lymphoma refractory to chimeric antigen receptor T‐cell therapy
por: Weinstock, Matt, et al.
Publicado: (2022)

Inelastic proton-proton scattering at 925 Mev
por: Hughes, I S, et al.
Publicado: (1956)

Standards of Value: Theory and Applications
por: Fishman, Jay
Publicado: (2013)

Commentary: The Advisory Committee on Immunization Practices’ ethical principles for allocating initial supplies of COVID-19 vaccine — United States, 2020
por: Fishman, Jay
Publicado: (2021)

Microbial biogeography of 925 geothermal springs in New Zealand
por: Power, Jean F., et al.
Publicado: (2018)

SUN-925 Carcinoid: A Crisis in the Upside Down
por: Arzeno, Luis E, et al.
Publicado: (2020)

Molecular mechanism of the wake-promoting agent TAK-925
por: Yin, Jie, et al.
Publicado: (2022)

Infectious Disease Transmission during Organ and Tissue Transplantation
por: Greenwald, Melissa A., et al.
Publicado: (2012)

Infection in Kidney Transplant Recipients
por: Fishman, Jay A.
Publicado: (2014)

Detection and genetic characterization of community-based SARS-CoV-2 infections — New York City, March 2020
por: Fishman, Jay A.
Publicado: (2020)

Next-Generation Sequencing for Identifying Unknown Pathogens in Sentinel Immunocompromised Hosts
por: Fishman, Jay A.
Publicado: (2023)

ISR Proton Balance Run 925 - 6.4.1978
por: Halvarsson, Bjorn
Publicado: (1978)

925. Healthcare-Associated Legionnaires’ Disease, California, 2015–2017
por: Kim, Janice, et al.
Publicado: (2018)

Association of bridging therapy utilization with clinical outcomes in patients receiving chimeric antigen receptor (CAR) T-cell therapy
por: Johnson, P Connor, et al.
Publicado: (2022)

Infection in Renal Transplant Recipients
por: Fishman, Jay A., et al.
Publicado: (2005)

The Pathogenesis and Diagnosis of Pneumocystis jiroveci Pneumonia
por: Apostolopoulou, Anna, et al.
Publicado: (2022)

Macroevolutionary constraints on global microbial diversity
por: Fishman, Ford J., et al.
Publicado: (2023)

925. Adverse Events Due to Inappropriate Prescribing in Older Adults Living with HIV
por: Cinquegrani, Mark, et al.
Publicado: (2020)

CAR-Based Approaches to Cutaneous T-Cell Lymphoma
por: Scarfò, Irene, et al.
Publicado: (2019)

Donor-derived infection—the challenge for transplant safety
por: Fishman, Jay A., et al.
Publicado: (2014)

Viruses
por: Martin, Stanley I., et al.
Publicado: (2009)

Infection in Renal Transplant Recipients
por: Fishman, Jay A., et al.
Publicado: (2008)

Chimeric Antigen Receptor beyond CAR-T Cells
por: Qin, Vicky Mengfei, et al.
Publicado: (2021)

Cytomorphology of Chimeric Antigen Receptor T-Cells (CAR-T)
por: Galli, Eugenio, et al.
Publicado: (2021)

Humanized Chimeric Antigen Receptor (CAR) T cells
por: Kozani, Pouya Safarzadeh, et al.
Publicado: (2021)

COVID‐19 and venous thromboembolism: A narrative review
por: Angelini, Dana E., et al.
Publicado: (2022)

Antiplatelet medications and risk of intracranial hemorrhage in patients with metastatic brain tumors
por: Miller, Eric J., et al.
Publicado: (2022)

Venous thromboembolism prophylaxis for hospitalized adult patients: a survey of US health care providers on attitudes and practices
por: Lam, Barbara D., et al.
Publicado: (2023)

An Amino Acid Substitution (L925V) Associated with Resistance to Pyrethroids in Varroa destructor
por: González-Cabrera, Joel, et al.
Publicado: (2013)

Src SUMOylation Inhibits Tumor Growth Via Decreasing FAK Y925 Phosphorylation
por: Wang, Jing, et al.
Publicado: (2017)

925. Oseltamivir usage in community settings: data from a household transmission study
por: Mellis, Alexandra, et al.
Publicado: (2023)

Killing Mechanisms of Chimeric Antigen Receptor (CAR) T Cells
por: Benmebarek, Mohamed-Reda, et al.
Publicado: (2019)

1105. The Burden of Infections Prior to Chimeric Antigen Receptor (CAR) Modified T-cell Therapy Predicts Post-CAR T-cell Infectious Complications
por: Garner, Will, et al.
Publicado: (2020)

MON-925 A Wolf in Sheep’s Clothing: Intermittent Hypercalcemia from an Intrathyroidal Parathyroid Carcinoma
por: Trejo, Jonathan, et al.
Publicado: (2020)

Discovery of TAK-925 as a Potent, Selective, and Brain-Penetrant Orexin 2 Receptor Agonist
por: Fujimoto, Tatsuhiko, et al.
Publicado: (2022)

Genomic presence of recombinant porcine endogenous retrovirus in transmitting miniature swine
por: Martin, Stanley I, et al.
Publicado: (2006)

Everolimus and Bevacizumab in the Management of Recurrent, Progressive Intracranial NF2 Mutated Meningioma
por: Mathew Thomas, Vinay, et al.
Publicado: (2019)

Chordoma: A Case Report and Review of Literature
por: Noor, Arish, et al.
Publicado: (2020)

Metabolic and Mitochondrial Functioning in Chimeric Antigen Receptor (CAR)—T Cells
por: Rad S. M., Ali Hosseini, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_77iro4j1s2ocrsmetnjo0edg3i